Finding the best marijuana stocks to buy gained the interest of more investors over the past few years, with big market drivers being companies entering more states and countries that are moving towards legalizing cannabis for both medical and recreational use. The potential for growth in this sector can be attributed to several key factors. To start is the growing acceptance of cannabis, and companies within this sector now diversifying their offerings. Next would be the many regions currently in various stages of legalizing cannabis.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Novo Nordisk's drastic selloff may be attributed to the management overpromising CagriSema's 25% weight loss target along with the decelerating top-line growth trend. The company now faces numerous headwinds from the Centers for Medicare and Medicaid Services, GLP1 compounders, and new biotech companies. Even so, we believe that the correction has been overly done, with NVO now trading way below its 10Y P/E means and its direct competitors.

Amazon's (NASDAQ: AMZN) Q4 and FY 2024 earnings report, released on February 6, was a double beat. Even though both earnings per share (EPS) and revenue came in above estimates, the markets weren't exactly satisfied.

Even after buying the $1.5 billion in stock, Schwab will still have $7.2 billion remaining under its existing stock-buyback program.

McDonald's global same-store sales climbed 0.4% in the fourth quarter, despite a drop of 1.4% in the US. An E. coli outbreak in the US scared customers away halting some momentum.

ON Semiconductor Corp. (ON) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.25 per share a year ago.

Intel has lost 65% in value since 2021 and has suspended its dividend. Intel's core x86 CPU business is losing market share to AMD, while Intel's gross margin is also far behind its peers. Intel's new leadership faces urgent decisions to avoid falling further behind competitors like AMD, NVIDIA, and TSMC in key growth markets.

Bulk-buying, bargain-hunting shoppers propelled Costco Wholesale (COST -0.57%) to a record-breaking 2024 for sales and earnings. The discount retailer is benefiting from a resilient economic backdrop while capitalizing on an ongoing e-commerce expansion.

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Dimitris Moraitis as Vice President of Strategy & Operations. Mr. Moraitis brings over 25 years of experience in strategic planning, operations, and business development within the pharmaceutical sector.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128404&wire=1 or contact Joseph E. Levi, Esq.

RADNOR, PA / ACCESS Newswire / February 10, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ:CROX) ("Crocs" or the "Company") on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the "Class Period"). This action, captioned Carretta v.

Shares of tech giant Qualcomm Inc. NASDAQ: QCOM have been stuck in a holding pattern for months, but recent signs point to a shift in momentum. After a largely sideways trend since July, the stock has gained 10% since December.

Take-Two Interactive chairman and CEO Strauss Zelnick joins 'Squawk Box' to discuss the company's quarterly earnings results, state of gaming, gaming release pipeline, regulatory and M&A outlook under the new Trump administration, latest news on Grand Theft Auto VI, impact of AI on gaming, and more.

The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities. The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities.

In the current state of the stock market, investors argue over whether valuations are too high. Some see historical indicators as signs of doom, while others feel that future earnings will justify prices.

MIAMI, FL / ACCESS Newswire / February 10, 2025 / The recent executive order banning paper straws in the United States marks a pivotal shift in sustainability policy. While well-intentioned, the push for alternatives like Paper Pulp and new chemistry for plastics has been proven problematic and with significant commercial challenges -prone to breaking down, leaving a poor user experience, and requiring resources that aren't always greener.

First Jointly Developed AI Agent Helps Customers Maximize Cisco Investments and Boosts Productivity News Summary: Powerful Partnership: The first of several AI agents being developed by Cisco with Mistral AI as a strategic technology partner, to help drive Cisco's Customer Experience (CX) move towards an Agentic-AI-Led future. AI-Powered Efficiency: The AI Renewals Agent streamlines and enhances the creation process for Cisco's Renewals team by analyzing data from 50 sources to build custom proposals tied to customer outcomes.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ:SAVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cassava securities between February 7, 2024 and November 24, 2024, both dates inclusive (the "Class Period").

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for colon cancer, rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer1 and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in.